S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ALXO ALX Oncology Holdings Inc

16.94

-0.08 (-0.47%)

After Hours

Last Updated: 07:30:00

Delayed by 15 minutes

ALX Oncology ties up with Tallac in cancer immunotherapeutics push

To read the full story on Seeking Alpha, click here.

ALX Oncology (NASDAQ:ALXO)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more ALX Oncology Charts.

ALX Oncology (NASDAQ:ALXO)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more ALX Oncology Charts.

ALX Oncology Holdings Inc News

ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer
Tuesday 30 April 2024 (1 day ago) • GlobeNewswire Inc.

ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting
Thursday 25 April 2024 (1 week ago) • GlobeNewswire Inc.

ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (“R/R B-NHL”)
Wednesday 10 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.

ALX Oncology Announces Two Evorpacept Clinical Abstracts Accepted for Presentation at the AACR Annual Meeting
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 17 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 17 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 17 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 6 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

More ALX Oncology Holdings Inc News Articles

Sterling vs AUD

Australia And New Zealan...

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions